Zealand pharma a s

Major-Pharmaceuticals

ZEAL


Smedeland 36
Copenhagen , 2600

Executive/
Director

Links

Price

  • Last Close
  • $ 18.16
    $ +0.54 3.05 %
    Sep 21, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 842
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 10.4% 46.6% -5% -11.1% -27.1% - -
Q2 - - - -15.2% 18% 4% -8.1% -16.3% - -
Q3 - - 7.7% 27.6% 16.3% 8% 0.3% 39.6% - -
Q4 - - -28.1% -29.4% 39.7% -5.4% -27.5% - - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%-15%204%2%-41%-15%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021
Q1 - - - -0.49 -0.63 -0.74 -0.94
Q2 - - 0.54 -0.67 -0.65 -0.23 -1.11
Q3 - - 0.23 4.68 -0.51 -0.9 -0.73
Q4 - - 0.58 -0.52 -0.74 -1.51 -
A 0 0 1.4 3 -2.5 -3.4 -2.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover 1.4 - - - -
Fixed Asset Turnover 1 0.2 0.8 4.1 0.7
Total Asset Turnover 0.2 - - 0.2 0.3
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -14.6 35.9 9.2 -9.5 -3
Equity multiplier 0.3 0.1 0.1 0.1 1.2